trial · primary record
Meropenem Infusion
Sepsis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 398 |
| Primary completion | 2028-12 |
| Primary endpoint | 28-day mortality |
| Registry ID | NCT07813767 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:13.108Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07813767
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.